Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.

Articles Posted in Product Liability

At least 50 federal and state lawsuits have been filed against Bayer due to serous side effects associated with Yasmin / Yaz.

Both the drugs are oral contraceptives that contain synthetic versions of the hormones estrogen and progestin, and are associated with side effects including stroke, heart attack, pulmonary embolism, deep vein thrombosis, gallbladder problems, and kidney problems.

Lawsuits have been filed against Bayer, the manufacturer of Yaz and Yasmin, alleging the company failed to adequately warn patients and physicians of the increased risk of serious adverse effects from Yaz Birth Control Medication. In certain cases, women have died due to these adverse effects of Yaz Birth Control.

Continue reading

Asbestos is well recognized as a health hazard and is highly regulated. An estimated 1.3 million employees in the construction and general industry face significant asbestos exposure on the job. Heaviest exposures occur in the construction industry, particularly during the removal of asbestos during renovation or demolition.

Employees are also likely to be exposed during the manufacture of asbestos products (such as textiles, friction products, insulation, and other building materials) and during automotive brake and clutch repair work.

Continue reading

A federal court has granted summary judgment to the defendant. Kilpatrick v. Breg, Inc., No. 4:08-cv-10052 (S.D. Fla. 6/26/09), in what appears to be the first substantive decision to come out of the multiple suits alleging that a pain pump medical device damages patients.

Judge Michael Moore ruled in favor of medical device manufacturer Breg, finding that the plaintiff, who alleged damage to his shoulder cartilage, did not provide enough reliable expert evidence to link the condition to the defendant’s shoulder pain pump.

Plaintiff Kilpatrick underwent arthroscopic shoulder surgery in 2004 after an orthopedic specialist discovered a tear in his shoulder socket. To help with post-operative pain, the surgeon inserted a pain pump into plaintiff’s shoulder, which would allow the doctor to administer an anesthetic via a catheter in the patient’s arm.

The surgeon injected bupivacaine into the pump’s attached catheter and further filled it with 100 ccs of anesthetic, which was to be delivered into Kilpatrick’s shoulder over the next 48 hours.

Plaintiff alleges that he began experiencing severe pain in his shoulder in 2006. An orthopedic surgeon diagnosed the pain as glenohumeral chondrolysis, a deterioration of the cartilage, and Kilpatrick underwent shoulder replacement surgery.

He then brought suit, alleging negligence, strict products liability, and violations of Florida’s Deceptive and Unfair Trade Practices Act. Kilpatrick claimed that using the Breg pain pump to administer local anesthetic directly into his shoulder joint caused him to develop post-arthroscopic glenohumeral chondrolysis.

Continue reading

One of the more recent contraceptive pills to come out on the market and which became quite popular very quickly was the Yaz pill which is manufactured by Bayer. Yaz claimed that it could treat moderate acne and that it would treat the symptoms of premenstrual dysphoric disorder.

However, Yaz may not be as safe or as beneficial as it claims. A new British report has outlined the risks and problems associated with Yaz. While all oral contraceptives carry a risk of causing blood clots in those who take them, Yaz seems to have an increased risk of these clots. While the dosage of hormones in a birth control pill has been known to affect the occurrence of blood clots, it also appears to be that the type of hormone may increase risk as well. Nearly all oral contraceptive pills contain estrogen and progestin and the lowest doses of estrogen correspond with the lowest risk for blood clots.

Continue reading

As a general rule, all hormonal birth control medications are associated with side effects and health risks, and the oral contraceptive pills YAZ, Yasmin, and Ocella are no exception.

Blood clots can cause serious side effects; stroke, heart attack, pulmonary embolism, and deep vein thrombosis.

A blood clot, or thrombosis, which begins in one part of the body can become an embolus, a blood clot that travels in the bloodstream. This embolus can migrate into any organ but usually migrates into the lungs, heart, or brain.

A deep vein thrombosis, or DVT, is a thrombosis which most commonly forms in the lower legs’ calf veins. A pulmonary embolism, or PE is a thrombosis which forms in or has moved into the lungs. Thrombosis which develops in the heart can break off and migrate to the brain leading to strokes.

Read new British Medical Journal article on Oral Contraceptives and Thromboembolism

Continue reading

Yamaha Motor Co., the world’s second-largest motorcycle maker, is not liable for damages to the family of a Texas teenager who died while driving the company’s Rhino all-terrain vehicle.

Jurors in state court in Orange, Texas, deliberated about two hours before ruling the vehicle wasn’t to blame for the death of 13-year-old Forest “Eddie” Ray in 2007. The Rhino, a cross between a golf cart and an ATV, has been linked to 59 deaths in the U.S. The case is the first of about 500 to go to trial.

Continue reading

Since the Chantix black box warning was announced earlier in July 2009, the focus has been on the increased risk of suicides. Pfizer also quietly added new information to the warning label about reports of serious skin reactions, such as Stevens-Johnson Syndrome.

Stevens-Johnson Syndrome, referred to as SJS, is a rare skin reaction that can occur as a side effect of several medications. It results in severe rashes and blistering of the skin and mouth.

It often requires treatment in a hospital intensive care unit (ICU) or burn care unit, and it can result in death. If the top layer of the skin detaches from the lower layers and lesions cover more than 30% of the body, SJS is often diagnosed as Toxic Epidermal Necrolysis (TEN).

Continue reading

Johnson & Johnson warned doctors of reports of a deadly skin reaction and liver failure tied to its HIV medicine Intelence.

The skin condition called toxic epidermal necrolysis has killed one patient and injured another since Intelence was approved in January 2008. Another patient taking the tablets reported a hypersensitivity reaction accompanied by liver failure.

The prescribing information for Intelence was revised to include these reports and a caution that doctors stop treatment immediately if patients develop severe skin reactions or hypersensitivity symptoms, according to a letter e-mailed today by the U.S. Food and Drug Administration. Similar side effects were seen in some study participants and have also been linked to other drugs for HIV, the virus that causes AIDS.

Continue reading

It only took a few hours for Southeast Texas jurors in the first trial over Yamaha Rhino all-terrain vehicle rollovers to return a swift ruling of no negligence — a verdict in the company’s favor that could have far reaching effects.

With hundreds of Yamaha ATV suits pending in courts around the country, the victorious outcome obtained in Orange County may influence how Yamaha proceeds with similar litigation.

The product liability trial of Johnny Ray vs. Yamaha Motor Co. kicked off Aug. 18 and ended Aug. 27.

Jurors in the Orange County District Court of Judge Buddy Hahn were tasked to decide if Yamaha Motor Co. cut costs and negligently placed a defective off-road vehicle into the stream of commerce.

Continue reading

An advertisement for Johnson & Johnson’s (JNJ) Ertaczo, a product to treat the fungal infection known as athlete’s foot, makes unproven claims about the medicine’s effectiveness and omits key information about risks associated with the product, federal regulators said on Wednesday.

The Food and Drug Administration said Johnson & Johnson used “misleading” information and did not mention certain risks in a medical journal advertisement for its athlete’s foot cream Ertaczo.

In an Aug. 21 letter released by the FDA Wednesday, the agency said the journal advertisement broadens the approved indication, contains unsubstantiated effectiveness claims about the product, and omits important risk information. Also, the FDA said J&J failed to submit the journal advertisement under current FDA regulations.

The company has until Sept. 4 to respond to the FDA letter.

“We have received an untitled letter from the FDA, which we are currently reviewing, and are in the process of preparing our response to the FDA,” said Marc Boston, a spokesman for J&J’s Ortho Dermtalogics unit, in a statement.

Continue reading

Contact Information